'Surgeon-tailored' mesh repair resolves urinary incontinence

August 9, 2012
'Surgeon-tailored' mesh repair resolves urinary incontinence
"Surgeon-tailored" polypropylene mesh repair using a transobturator midurethral sling procedure alone or in combination with pelvic organ prolapse repair is an effective treatment for stress urinary incontinence symptoms, although some concerns remain regarding mesh-related complications, according to a study published in the August issue of Urology.

(HealthDay) -- "Surgeon-tailored" polypropylene mesh (STPM) repair using a transobturator midurethral sling procedure alone or in combination with pelvic organ prolapse repair is an effective treatment for stress urinary incontinence symptoms, although some concerns remain regarding mesh-related complications, according to a study published in the August issue of Urology.

Fikret Fatih Önol, M.D., of the Ümraniye Training and Research Hospital in Istanbul, and colleagues conducted a study involving 52 women with stress urinary incontinence and pelvic who were treated with transobturator midurethral sling alone, and 74 women who received concomitant pelvic organ prolapse repair. One-hundred eighteen women were available for follow-up.

During follow-up the researchers found that 86.4 and 81.1 percent of sling-treated and sling plus pelvic organ prolapse repair patients, respectively, were cured of their stress urinary incontinence. Nearly all (98.6 percent) patients were cured of their pelvic organ prolapse. Preoperative urge symptoms resolved for 53.8 and 62.5 percent of sling and sling plus pelvic organ prolapse repair patients, respectively; however, new urge symptoms developed in 22 and 15 percent, respectively. In 11 patients (14.8 percent) who underwent concomitant pelvic organ prolapse repair vaginal mesh erosions were observed.

"STPM may represent a cost-effective option for stress treatment. Concomitant pelvic organ prolapse repair with STPM does not affect incontinence outcomes and provides high anatomic success and patient satisfaction in the long term," the authors write. "An improved understanding of the risk factors for mesh erosion, development of more bio-compatible implant materials, and better definition of patient selection criteria will define the role of transvaginal surgery for prolapse management in the future."

Explore further: Findings provide guide to decisions on use of slings for women's prolapse surgery

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Findings provide guide to decisions on use of slings for women's prolapse surgery

June 20, 2012
A multicenter study involving a UT Southwestern Medical Center urogynecologist will eliminate some of the guesswork physicians face about whether to use a sling during vaginal prolapse repair to prevent urinary incontinence.

PISQ-12 validated for patients with pelvic organ prolapse

March 3, 2012
(HealthDay) -- The Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) has been shown to be a valid measure of sexual function in patients who undergo surgical mesh implantation for treatment of pelvic ...

Researchers offer hope to prolapse sufferers

May 17, 2011
Scientists in Scandinavia have found a new way to treat sufferers of pelvic organ prolapse. Presented in the New England Journal of Medicine, their study reveals that the use of synthetic mesh can have a more beneficial effect ...

Transvaginal mesh op restores pelvic organ prolapse at price

May 26, 2012
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to a study published ...

Recommended for you

New cellular approach found to control progression of chronic kidney disease

December 15, 2017
Researchers have demonstrated for the first time that extracellular vesicles - tiny protein-filled structures - isolated from amniotic fluid stem cells (AFSCs) can be used to effectively slow the progression of kidney damage ...

Testing shows differences in efficacy of Zika vaccines after one year

December 15, 2017
(Medical Xpress)—A large team of researchers with members from Harvard Medical School, Walter Reed Army Institute of Research, Bioqual Inc. and MIT has found that the efficacy of the three types of Zika vaccines currently ...

How to regulate fecal microbiota transplants

December 15, 2017
(Medical Xpress)—A small team of researchers at the University of Maryland, some with affiliations to the Veterans Affairs Maryland Health Care System, has written and published a Policy Forum piece in the journal Science ...

Screening could catch a quarter of hip fractures before they happen

December 15, 2017
Community screening for osteoporosis could prevent more than a quarter of hip fractures in older women - according to new research led by the University of East Anglia (UEA).

Urine test developed to test for tuberculosis

December 14, 2017
(Medical Xpress)—An international team of researchers has developed a urine test that can be used to detect tuberculosis (TB) in human patients. In their paper published in Science Translational Medicine, the group describes ...

40 years after first Ebola outbreak, survivors show signs they can stave off new infection

December 14, 2017
Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks, according to a new study ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.